Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucosamine sulfate versus paracetamol in knee osteoarthritis with plasma and synovial fluid pharmacokinetics
2007-001501-13Phase 2Terminated
- Sponsor
- Rottapharm Biotech
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in knee osteoarthritis (OA) comparing Glucosamine sulfate with Paracetamol (2 arms). Primary endpoints: Glucosamine concentrations in plasma and synovial fluid and Efficacy and safety on knee osteoarthritis symptoms. Started Aug 2007; status: terminated.
02
Drugs
glucosamine sulphateacetaminophen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2007-001501-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001501-13.